Curenetics

Curenetics is an innovative cancer med-tech. We leverage genomic, histological and clinico-demographic data to develop personalised predictive models of a patient’s response to cancer immunotherapy.

Medical

Past Raises
2022 £550,000 Closed

We act as an investment opportunity aggregator, collecting hundreds of investment opportunities from across the UK.

If you'd like your events, opportunities and news listed here please join free as an organisation.